Vigilant Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-600
| Closed | -$50K | – | 465 |
|
|
2023
Q1 | $50K | Buy |
+600
| New | +$49.7K | ﹤0.01% | 271 |
|
|
2021
Q2 | – | Sell |
-100
| Closed | -$6K | – | 445 |
|
|
2021
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 336 |
|
|
2020
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 307 |
|
|
2020
Q3 | $6K | Sell |
100
-100
| -50% | -$6.93K | ﹤0.01% | 326 |
|
|
2020
Q2 | $15K | Hold |
200
| – | – | ﹤0.01% | 263 |
|
|
2020
Q1 | $15K | Hold |
200
| – | – | ﹤0.01% | 268 |
|
|
2019
Q4 | $13K | Buy |
+200
| New | +$13K | ﹤0.01% | 410 |
|
|
2019
Q2 | – | Sell |
-752
| Closed | -$49K | – | 447 |
|
|
2019
Q1 | $49K | Sell |
752
-3,404
| -82% | -$226K | 0.01% | 248 |
|
|
2018
Q4 | $260K | Sell |
4,156
-552
| -12% | -$38.6K | 0.04% | 103 |
|
|
2018
Q3 | $364K | Sell |
4,708
-666
| -12% | -$50.3K | 0.05% | 98 |
|
|
2018
Q2 | $381K | Sell |
5,374
-968
| -15% | -$68.4K | 0.06% | 88 |
|
|
2018
Q1 | $478K | Sell |
6,342
-7
| -0.1% | -$556 | 0.07% | 81 |
|
|
2017
Q4 | $455K | Buy |
6,349
+2,197
| +53% | +$167K | 0.06% | 91 |
|
|
2017
Q3 | $336K | Buy |
4,152
+400
| +11% | +$30.6K | 0.05% | 89 |
|
|
2017
Q2 | $266K | Hold |
3,752
| – | – | 0.04% | 94 |
|
|
2017
Q1 | $255K | Sell |
3,752
-1,000
| -21% | -$70.3K | 0.04% | 94 |
|
|
2016
Q4 | $340K | Sell |
4,752
-6
| -0.1% | -$446 | 0.06% | 92 |
|
|
2016
Q3 | $376K | Buy |
4,758
+227
| +5% | +$18.4K | 0.07% | 90 |
|
|
2016
Q2 | $378K | Buy |
4,531
+6
| +0.1% | +$532 | 0.07% | 81 |
|
|
2016
Q1 | $416K | Sell |
4,525
-675
| -13% | -$60.9K | 0.08% | 74 |
|
|
2015
Q4 | $526K | Hold |
5,200
| – | – | 0.11% | 77 |
|
|
2015
Q3 | $511K | Buy |
5,200
+90
| +2% | +$10K | 0.1% | 77 |
|
|
2015
Q2 | $598K | Buy |
5,110
+310
| +6% | +$33.9K | 0.11% | 81 |
|
|
2015
Q1 | $471K | Sell |
4,800
-360
| -7% | -$36.6K | 0.09% | 84 |
|
|
2014
Q4 | $486K | Buy |
5,160
+4,000
| +345% | +$414K | 0.1% | 86 |
|
|
2014
Q3 | $123K | Hold |
1,160
| – | – | 0.03% | 108 |
|
|
2014
Q2 | $96K | Hold |
1,160
| – | – | 0.02% | 110 |
|
|
2014
Q1 | $82K | Hold |
1,160
| – | – | 0.02% | 126 |
|
|
2013
Q4 | $87K | Hold |
1,160
| – | – | 0.02% | 119 |
|
|
2013
Q3 | $73K | Hold |
1,160
| – | – | 0.02% | 116 |
|
|
2013
Q2 | $59K | Buy |
+1,160
| New | +$60.5K | 0.02% | 126 |
|
Other funds holding GILD
Vigilant Capital Management's GILD Position: Q2 2023 in Review
Vigilant Capital Management sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 600 shares — an estimated $50K sold.
Vigilant Capital Management first reported a position in GILD in Q2 2013 and held it in 31 quarters. The position peaked at $598K in Q2 2015. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.
- Vigilant Capital Management reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
- Vigilant Capital Management sold 600 Gilead Sciences shares in Q2 2023, an estimated $50K.
- Vigilant Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 31 quarters.
- Vigilant Capital Management's Gilead Sciences position peaked at $598K in Q2 2015.
- 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.
Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.